Related Experiment Videos
Inhibition of chemical carcinogenesis by retinoids
Abstract:
Retinoids are effective inhibitors of chemical carcinogenesis in the mammary gland, esophagus, and urinary bladder of experimental animals. Modification of the basic retinoid structure has produced retinoids with increased target organ specificity, resulting in increased anticancer activity with reduced systemic toxicity. Combining retinoid treatment with hormonal manipulation results in a synergistic inhibition of mammary carcinogenesis; this combination approach also inhibits mammary tumor recurrence following surgical removal of the first mammary tumor. Retinoids are most effective when administered shortly after the carcinogenic insult. However, even when retinoid treatment if delayed, the compounds are still effective cancer chemopreventive agents for the mammary gland and urinary bladder. The length of time that retinoid exposure can be delayed and retain an anticancer effect is directly related to tumor latency, with a longer delay permissible against tumors with long latent periods. Current research focuses on the identification of new retinoids with increased chemopreventive activity and decreased toxicity, and combination studies which will provide treatment regimens with increased anticancer activity as well as information pertaining to mechanisms of retinoid action.
Insights
Retinoids show promise in preventing chemical carcinogenesis in various organs. Modified retinoids and combination therapies enhance anticancer activity while reducing toxicity.
Area of Science:
- Oncology
- Chemoprevention
- Drug Development
Background:
- Retinoids are established chemopreventive agents against chemical carcinogenesis in multiple organs.
- Structural modifications have yielded retinoids with improved organ specificity, efficacy, and safety profiles.
- Combination therapies, particularly with hormonal manipulation, demonstrate synergistic effects in cancer prevention.
Purpose of the Study:
- To evaluate the efficacy of retinoids and their modified analogs in cancer chemoprevention.
- To investigate the synergistic effects of combining retinoid treatment with hormonal manipulation.
- To explore the impact of treatment timing and tumor latency on retinoid efficacy.
Main Methods:
- Administration of retinoids and combination therapies in experimental animal models.
- Assessment of anticancer activity and systemic toxicity.
- Evaluation of treatment timing relative to carcinogenic insult and tumor latency.
Main Results:
- Retinoids effectively inhibit carcinogenesis in the mammary gland, esophagus, and urinary bladder.
- Modified retinoids exhibit enhanced anticancer activity and reduced toxicity.
- Combination therapy with hormonal manipulation synergistically inhibits mammary carcinogenesis and prevents tumor recurrence.
- Retinoids remain effective even when administered with delay, particularly for tumors with longer latent periods.
Conclusions:
- Retinoids are valuable chemopreventive agents with potential for therapeutic application.
- Optimized retinoid structures and combination strategies offer improved cancer prevention and treatment outcomes.
- Further research is warranted to identify novel retinoids and elucidate mechanisms of action for enhanced chemoprevention.